Suppr超能文献

哮喘的补充和替代医学的系统评价与荟萃分析。

A systematic review and meta-analysis of complementary and alternative medicine in asthma.

作者信息

Kohn Charlotte M, Paudyal Priyamvada

机构信息

Division of Primary Care and Public Health, Brighton and Sussex Medical School, Brighton, UK.

Division of Primary Care and Public Health, Brighton and Sussex Medical School, Brighton, UK

出版信息

Eur Respir Rev. 2017 Jan 31;26(143). doi: 10.1183/16000617.0092-2016. Print 2017 Jan.

Abstract

Asthma is a chronic, inflammatory lung disease affecting around 235 million people worldwide. Conventional medications in asthma are not curative and patients have significant concerns regarding their side-effects. Consequently, many asthma patients turn to complementary and alternative medicine (CAM) for a more holistic approach to care. We systematically reviewed the available evidence on the effectiveness of CAM in the management of asthma in adults.We searched the MEDLINE, EMBASE, CINAHL, AMED and Cochrane databases for randomised controlled trials published in English between 1990 and 2016 investigating the effectiveness of oral or topical CAM in asthmatic adults. The quality of the studies was assessed using the Cochrane Risk of Bias Assessment Tool.In all, 23 eligible trials were identified covering 19 different CAMs. Overall, there was limited evidence on the effectiveness of CAM in adult asthma as most CAMs were only assessed in a single trial. CAMs with multiple trials provided null or inconsistent results. Many of the trials were rated as having high risk of bias.The existing evidence is insufficient to recommend any of the oral and topical CAMs in the management of asthma in adults.

摘要

哮喘是一种慢性炎症性肺部疾病,全球约有2.35亿人受其影响。哮喘的传统药物无法治愈疾病,且患者对其副作用极为担忧。因此,许多哮喘患者转向补充和替代医学(CAM),寻求更全面的治疗方法。我们系统回顾了关于补充和替代医学在成人哮喘管理中有效性的现有证据。我们检索了MEDLINE、EMBASE、CINAHL、AMED和Cochrane数据库,查找1990年至2016年间发表的英文随机对照试验,这些试验调查了口服或外用补充和替代医学对成年哮喘患者的有效性。使用Cochrane偏倚风险评估工具对研究质量进行评估。总共确定了23项符合条件的试验,涵盖19种不同的补充和替代医学。总体而言,补充和替代医学在成人哮喘治疗中的有效性证据有限,因为大多数补充和替代医学仅在一项试验中进行了评估。进行了多项试验的补充和替代医学得出了无效或不一致的结果。许多试验被评为具有高偏倚风险。现有证据不足以推荐任何口服和外用补充和替代医学用于成人哮喘的管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3872/9488626/6ba4a96d4022/ERR-0092-2016.01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验